News

ISG Launches Study to Assess Mainframe Providers for Public Sector

ISG Launches Study to Assess Mainframe Providers for Public Sector

ISG Initiates Research on Mainframe Service Providers

Information Services Group (NASDAQ: III), a renowned global technology research and advisory firm, has embarked on a new research initiative. This study focuses on evaluating providers that offer mainframe computing system modernization services for U.S. public sector organizations. In a time where technology continues to advance at a remarkable pace, this research aims to scrutinize how these providers can help optimize legacy systems.

Upcoming ISG Provider Lens Report

The findings from this extensive study will be compiled into the upcoming ISG Provider Lens™ report titled "Mainframes - Services and Solutions 2025." Scheduled for release in March 2025, the report will delve into various providers and software solutions that play a pivotal role in the modernization of mainframe systems. Such modernization is essential for these systems to evolve and align with the digital business requirements of today and the future.

Importance of Modernization in the Public Sector

Organizations within the U.S. public sector, including state, local, municipal, and educational agencies, are increasingly looking towards modernization. They aim to enhance their capabilities by integrating legacy mainframe systems which have for decades supported their IT operations. Modernization efforts are driven by the need to enhance availability, interoperability, and cost-effectiveness within our digital age.

Heiko Henkes, managing director at ISG Provider Lens, shared insight into this initiative stating, "Although mainframes are founded on legacy programming languages and structures, modern techniques enable them to offer next-level digital services." This approach allows institutions to ensure that their mainframe applications can adapt and integrate with emerging technologies and new computing platforms seamlessly.

Evaluating Mainframe Application Services

Across the U.S. public sector market, ISG has engaged with more than 60 vendors and providers. The research team, in collaboration with ISG’s global advisors, will categorize these providers into four distinct quadrants representing key areas of mainframe application services—essential insights for organizations aiming to enhance their service provider collaborations.

Mainframe Optimization Services

This quadrant evaluates service providers that enable legacy application modernization with minimal disruption, allowing organizations to leverage contemporary technologies and practices effectively.

Application Modernization Services

This area focuses on application development and maintenance service providers who utilize advanced modernization methodologies to evaluate and rewrite legacy coding applications.

Mainframe-as-a-Service (MFaaS)

Here, infrastructure service providers that offer shared IBM Z mainframes under a pay-per-use model are assessed, giving public sector entities flexibility and scalability.

Mainframe Operations

This quadrant looks at traditional outsourcing providers, bringing to light those with significant experience in delivering mainframe-related services.

Geographical Insights and Analysis

This research is designed to not only focus on the public sector's requirements but will also analyze the global mainframe application support and services market as a whole. Lead analyst Peter Crocker is poised to direct these invaluable insights regarding products and services, especially tailored for the U.S. market.

For companies interested in being part of this transformative study, there are opportunities to identify themselves as mainframe application service providers. It is also encouraged for participants to share their experiences with particular vendors through ISG’s continuous CX research framework.

About ISG Provider Lens Research

The ISG Provider Lens™ Quadrant research series is distinctive, merging empirical, data-driven research with real-world insight from ISG’s experienced advisors. Enterprises can expect a wealth of actionable data and market analysis to guide their selections of sourcing partners while assisting ISG advisors in validating their market knowledge.

About ISG

ISG, also known as Information Services Group (NASDAQ: III), is a leading global research and advisory firm, dedicated to assisting public sector organizations and corporations in attaining operational excellence and driving pivotal growth. Its expertise spans digital transformation services, including automation, AI, cloud, data analytics, sourcing advisory, and risk governance.

Founded in 2006 and headquartered in Stamford, Connecticut, ISG boasts a team of over 1,600 industry professionals across more than 20 countries, recognized for their innovative thinking and deep technological knowledge.

Frequently Asked Questions

What is the focus of the ISG Provider Lens report?

The report will assess providers of mainframe modernization services essential for U.S. public sector organizations.

When will the ISG Provider Lens report be released?

The report is scheduled for publication in March 2025, featuring comprehensive market insights.

How many vendors will be evaluated in this study?

ISG has reached out to over 60 vendors, assessing their capabilities in serving the public sector market.

What are the main quadrants in the study?

The study will categorize services into Mainframe Optimization, Application Modernization, Mainframe-as-a-Service, and Mainframe Operations.

How does ISG's research support buyers?

The findings will help organizations evaluate vendor relationships and enhance their service procurement strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Updates for Edwards Lifesciences Corporation Investors

Updated Category News Views 157

Important Updates for Edwards Lifesciences Corporation Investors New York - Investors of Edwards Lifesciences Corporation (NYSE: EW) should remain aware of the recent developments concerning the securities class action lawsuit that affects their investments. This information is crucial for anyone who purchased securities of Edwards Lifesciences within the specified class...

Continue Reading
Investors Urged to Act: Zenas BioPharma Class Action Notice

Updated Category News Views 147

Investors Encouraged to Participate in Zenas BioPharma Class Action The Gross Law Firm has issued an important notice for shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO), urging those who have incurred financial losses to seek options regarding a pending class action. This notice highlights the importance of taking timely steps for potential recovery. Understanding...

Continue Reading
Zinzino's Strategic Merger with It Works! Enhances Growth Potential

Updated Category News Views 1021

Zinzino and It Works! Merger: A Game-Changer in Health Sales Zinzino AB has officially announced a remarkable merger with the US-based direct sales company It Works!, a bold and strategic decision that is set to enhance the distribution capabilities of both companies across various markets. This merger, which combines unique strengths and resources, opens new avenues for...

Continue Reading
NEXE Innovations Expands Compostable Product Line in North America

Updated Category News Views 164

Exciting Developments at NEXE Innovations Based in Windsor, Ontario, NEXE Innovations Inc. is making significant strides in the compostable materials industry. Recently, the company announced a pivotal delivery of over 80,000 compostable coffee pods, available in three new product SKUs, to an esteemed office coffee services distributor in North America. Expanding Product...

Continue Reading
SubSplit Acquires Ideal Consolidated: Legacy Meets Future

Updated Category News Views 236

Market moves may come and go, but the real power play is knowing when a strategic acquisition is worth its weight in gold. SubSplit Services Group just pulled off one such move by nabbing Ideal Consolidated, Inc., a company that's been a fixture in South Bend, Indiana, since 1956. Yeah, that's a lot of history, folks, and SubSplit's decision to add that to their portfolio...

Continue Reading